Charles O's most recent trade in Cincinnati Financial Corp. was a trade of 847 Common Stock done . Disclosure was reported to the exchange on Jan. 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cincinnati Financial | Charles O. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 847 | 746,581 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 51,478 | 0 (0%) | 0% | - | Common Stock | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 20,101 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 19,243 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 13,579 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 10,653 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 800 | 0 (0%) | 0% | - | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Sale of securities on an exchange or to another person at price $ 153.54 per share. | 15 Aug 2025 | 3,500 | 181,055 (0%) | 0% | 153.5 | 537,404 | Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O. Rossotti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 3,097 | 9,096 (0%) | 0% | 0 | Class A Common Stock | |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O. Rossotti | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2025 | 8,088 | 5,999 (0%) | 0% | 0 | Class A Common Stock | |
| Hannon Armstrong Sustainable infra Cap Inc | Charles M. O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,166 | 27,234 | - | - | LTIP Units | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 732,470 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,000 | 208,274 | - | - | Restricted Stock Units | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2025 | 276 | 64,907 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2025 | 138 | 745,734 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2025 | 138 | 29,513 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 971 | 745,596 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 27 Dec 2024 | 1,333 | 728,470 (0%) | 0% | - | Common Stock, par value $0.001 per share | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 27 Dec 2024 | 1,333 | 212,274 | - | - | Restricted Stock Units | ||
| Cincinnati Financial | Charles Schiff O. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2024 | 8,697 | 744,625 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 09 Dec 2024 | 40,000 | 213,607 | - | - | Options to purchase common stock | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 09 Dec 2024 | 40,000 | 727,137 (0%) | 0% | 4.0 | 160,400 | Common Stock, par value $0.001 per share | |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 98.19 per share. | 09 Dec 2024 | 15,738 | 103,075 (0%) | 0% | 98.2 | 1,545,314 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 101.16 per share. | 09 Dec 2024 | 7,304 | 120,862 (0%) | 0% | 101.2 | 738,873 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 99.14 per share. | 09 Dec 2024 | 1,761 | 118,813 (0%) | 0% | 99.1 | 174,586 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 98.75 per share. | 09 Dec 2024 | 1,445 | 128,846 (0%) | 0% | 98.8 | 142,694 | Class A Common Stock |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 09 Dec 2024 | 1,413 | 253,607 | - | - | Restricted Stock Units | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 09 Dec 2024 | 1,413 | 687,137 (0%) | 0% | - | Common Stock, par value $0.001 per share | ||
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 99.12 per share. | 09 Dec 2024 | 680 | 128,166 (0%) | 0% | 99.1 | 67,402 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 99.12 per share. | 09 Dec 2024 | 465 | 102,610 (0%) | 0% | 99.1 | 46,091 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 102.22 per share. | 09 Dec 2024 | 288 | 120,574 (0%) | 0% | 102.2 | 29,439 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 101.33 per share. | 04 Dec 2024 | 46,241 | 203,759 (0%) | 0% | 101.3 | 4,685,601 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 100.32 per share. | 04 Dec 2024 | 29,252 | 150,734 (0%) | 0% | 100.3 | 2,934,561 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 101.45 per share. | 04 Dec 2024 | 18,234 | 132,500 (0%) | 0% | 101.4 | 1,849,839 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 99.45 per share. | 04 Dec 2024 | 11,778 | 191,626 (0%) | 0% | 99.4 | 1,171,322 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 100.80 per share. | 04 Dec 2024 | 11,640 | 179,986 (0%) | 0% | 100.8 | 1,173,312 | Class A Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 102.04 per share. | 04 Dec 2024 | 2,209 | 130,291 (0%) | 0% | 102.0 | 225,406 | Class A Common Stock |
| Surmodics Inc | Olson W. Charles | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 959 | 51,478 (0%) | 0% | 39.9 | 38,274 | Common Stock |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale of securities on an exchange or to another person at price $ 101.90 per share. | 04 Dec 2024 | 355 | 203,404 (0%) | 0% | 101.9 | 36,175 | Class A Common Stock |
| Surmodics Inc | W. Charles Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,534 | 52,437 (0%) | 0% | 39.4 | 60,516 | Common Stock |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 21 Nov 2024 | 23,248 | 252,179 | - | - | Options to purchase common stock | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 21 Nov 2024 | 2,841 | 255,020 | - | - | Restricted stock units | ||
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 18,447 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. | 16 Aug 2024 | 18,447 | 70,698 (0%) | 0% | 33.2 | 612,440 | Common Stock |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. | 16 Aug 2024 | 16,727 | 53,971 (0%) | 0% | 40.1 | 670,084 | Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O Rossotti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 2,414 | 14,087 (0%) | 0% | 0 | Class A Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Sale of securities on an exchange or to another person at price $ 130.44 per share. | 31 Jul 2024 | 6,000 | 184,555 (0%) | 0% | 130.4 | 782,623 | Common Stock |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jul 2024 | 1,000 | 63,888 (0%) | 0% | 0 | Common Stock | |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 32.37 per share. | 30 Jun 2024 | 641 | 35,310 (0%) | 0% | 32.4 | 20,749 | Common Stock |
| Hannon Armstrong Sustainable infra Cap Inc | Charles M. O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,126 | 22,068 | - | - | LTIP Units | |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O Rossotti | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 14,000 | 11,673 (0%) | 0% | 0 | Class A Common Stock | |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 250,000 | 250,000 (0%) | 0% | 0 | Class A Common Stock | |
| Construction Partners Inc (Class A) | Charles E. Owens | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 May 2024 | 250,000 | 1,000,000 | - | - | Class B Common Stock | |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 33.26 per share. | 31 Mar 2024 | 623 | 34,669 (0%) | 0% | 33.3 | 20,721 | Common |
| Catalyst Pharma Inc | Charles O'Keeffe B. | Director | 15 Feb 2024 | 4,000 | 685,724 (0%) | 0% | - | Common Stock, par value $0.001 per share | ||
| Catalyst Pharma Inc | B. Charles O'Keeffe | Director | 15 Feb 2024 | 4,000 | 228,931 | - | - | Restricted Stock Units | ||
| Crawford & Co. (Class A) | Ogburn Charles H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 7,058 | 464,204 (1%) | 0% | 0 | Class A Common Stock | |
| Cincinnati Financial | Charles Schiff O. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 328 | 62,051 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 164 | 29,375 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles Schiff O. | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 164 | 735,928 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Schiff O. Charles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 889 | 735,764 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharma Inc | Charles O'Keeffe B. | Director | 02 Jan 2024 | 60,000 | 681,724 (0%) | 0% | 1.1 | 67,800 | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 02 Jan 2024 | 60,000 | 232,931 | - | - | Options to purchase common stock | ||
| Marinemax Inc | Oglesby R. Charles | Director | Grant, award, or other acquisition of securities at price $ 38.90 per share. | 31 Dec 2023 | 534 | 34,046 (0%) | 0% | 38.9 | 20,773 | Common |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 27 Dec 2023 | 1,333 | 621,724 (0%) | 0% | - | Common Stock, par value $0.001 per share | ||
| Catalyst Pharma Inc | O'Keeffe Charles B. | Director | 27 Dec 2023 | 1,333 | 292,931 | - | - | Restricted Stock Units | ||
| Catalyst Pharma Inc | B. O'Keeffe Charles | Director | 08 Dec 2023 | 29,524 | 290,024 | - | - | Options to purchase common stock | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 08 Dec 2023 | 4,240 | 294,264 | - | - | Restricted stock units | ||
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 20,101 | 20,101 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Olson W. Charles | SVP, Medical Device Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 6,302 | 52,251 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | W. Charles Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 842 | 45,949 (0%) | 0% | 32.8 | 27,634 | Common Stock |
| Surmodics Inc | Olson Charles W. | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 693 | 46,791 (0%) | 0% | 32.8 | 22,744 | Common Stock |
| Surmodics Inc | Charles W. Olson | SVP, Medical Device Coatings | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 650 | 47,484 (0%) | 0% | 32.8 | 21,333 | Common Stock |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 4,616 | 4,616 | - | - | Restricted Stock Units | |
| Marinemax Inc | Charles R. Oglesby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 4,044 | 0 | - | - | Restricted Stock Units | |
| Marinemax Inc | Charles R. Oglesby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 4,044 | 33,512 (0%) | 0% | 0 | Common Stock | |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 32.82 per share. | 30 Sep 2023 | 632 | 29,468 (0%) | 0% | 32.8 | 20,742 | Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O Rossotti | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 2,595 | 25,673 (0%) | 0% | 0 | Class A Common Stock | |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 34.16 per share. | 30 Jun 2023 | 607 | 28,836 (0%) | 0% | 34.2 | 20,735 | Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O Rossotti | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2023 | 13,000 | 23,078 (0%) | 0% | 0 | Class A Common Stock | |
| Booz Allen Hamilton Holding Corp (Class A) | Charles O Rossotti | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2023 | 6,500 | 36,078 (0%) | 0% | 0 | Class A Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Sale of securities on an exchange or to another person at price $ 102.74 per share. | 17 May 2023 | 20,000 | 190,555 (0%) | 0% | 102.7 | 2,054,776 | Common Stock |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 28.75 per share. | 31 Mar 2023 | 722 | 28,229 (0%) | 0% | 28.8 | 20,758 | Common Stock |
| Hannon Armstrong Sustainable infra Cap Inc | Charles M. O'Neil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 4,129 | 15,942 | - | - | LTIP Units | |
| Deere & Co. | Charles O. Holliday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 393 | 16,304 (0%) | 0% | 0 | $1 Par Common Stock | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 15 Feb 2023 | 4,000 | 620,391 (0%) | 0% | - | Common Stock, par value $0.001 per share | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 15 Feb 2023 | 4,000 | 260,500 | - | - | Restricted Stock Units | ||
| Crawford & Co. (Class A) | Charles H. Ogburn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 14,876 | 457,146 (1%) | 0% | 0 | Class A Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 260 | 59,971 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 130 | 734,875 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 130 | 29,211 (0%) | 0% | 0 | Common Stock | |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 24 Jan 2023 | 50,000 | 264,500 | - | - | Options to purchase common stock | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 24 Jan 2023 | 50,000 | 616,391 (0%) | 0% | 0.8 | 39,500 | Common stock, par value $0.001 per share | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jan 2023 | 600,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Jan 2023 | 300,000 | 733,795 (0%) | 0% | 0 | Common Stock | |
| Cincinnati Financial | Charles O. Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 950 | 734,745 (0%) | 0% | 0 | Common Stock | |
| Marinemax Inc | Charles R. Oglesby | Director | Grant, award, or other acquisition of securities at price $ 31.22 per share. | 31 Dec 2022 | 665 | 27,507 (0%) | 0% | 31.2 | 20,761 | Common Stock |
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 27 Dec 2022 | 15,000 | 310,500 | - | - | Options to purchase common stock | ||
| Catalyst Pharma Inc | Charles B. O'Keeffe | Director | 27 Dec 2022 | 4,000 | 314,500 | - | - | Restricted stock units |